Primary Prevention

• 

  Subject Areas on Research

  • "The education-knowledge road to Health for All--strategy for the 1990's". 
  • 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • A Community-based Assessment of Skin Care, Allergies, and Eczema (CASCADE): an atopic dermatitis primary prevention study using emollients-protocol for a randomized controlled trial. 
  • A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary Prevention. 
  • A case for community health programs for sickle cell anemia in low- to middle-income countries: An integrative review. 
  • A computerized tool for evaluating the effectiveness of preventive interventions. 
  • Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians. 
  • Adolescent dating violence: supports and barriers in accessing services. 
  • Advances in prevention and health services delivery 2010-2011. 
  • Advances in primary prevention and health services delivery. 
  • Advances in primary stroke prevention. 
  • Advances in stroke: Prevention and health services delivery 2012-2013. 
  • Advancing Health Policy and Program Research in Diabetes: Findings from the Natural Experiments for Translation in Diabetes (NEXT-D) Network. 
  • Age-related vulnerabilities of older adults with colon adenomas: evidence from Project Prevent. 
  • Allocating HIV-prevention resources: balancing efficiency and equity. 
  • American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. 
  • An examination of the process of relapse prevention therapy designed to aid smoking cessation. 
  • Analysing the relationship between change in a risk factor and risk of disease. 
  • Antiphospholipid antibody syndrome: current concepts. 
  • Aspirin for primary prevention of cardiovascular outcomes in diabetes mellitus: An updated systematic review and meta-analysis. 
  • Aspirin in cardiovascular disorders. What is the optimum dose? 
  • Assessing the appropriateness of ICD use "appropriately". 
  • Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination. 
  • Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention. 
  • Association of Primary Care Providers' Beliefs of Statins for Primary Prevention and Statin Prescription. 
  • Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol. 
  • Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data. 
  • Bridging Income Generation with Group Integrated Care for cardiovascular risk reduction: Rationale and design of the BIGPIC study. 
  • Burn prevention. 
  • Can a costly intervention be cost-effective? An analysis of violence prevention 
  • Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy. 
  • Cancer, clots and consensus: new understanding of an old problem. 
  • Cardiovascular Disease Prevention: Lifestyle Interventions for Primary Prevention. 
  • Cardiovascular Disease Prevention: Risk Assessment. 
  • Centers for Medicare and Medicaid Services' Decision to Reconsider Coverage Indications for ICDs: Where to Now? 
  • Changes in the nutrient content of school lunches: results from the Pathways study. 
  • Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem. 
  • Commentary: Lack of screening makes primary prevention most effective to reduce the mortality of aortic dissection. 
  • Community-Based multiple family groups to prevent and reduce violent and aggressive behavior: the GREAT Families Program. 
  • Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. 
  • Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women. 
  • Comparative Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Older Heart Failure Patients With Diabetes Mellitus. 
  • Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty. 
  • Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines. 
  • Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk. 
  • Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age. 
  • Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy. 
  • Cyclic coronary flow: defining preinfarction angina at the crossroads of unstable angina and myocardial infarction. 
  • Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults. 
  • Designing mental health interventions informed by child development and human biology theory: a social ecology intervention for child soldiers in Nepal. 
  • Disabling back injuries in nursing personnel. 
  • Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure. 
  • Do ICD lead recalls affect physician--or patient--behavior? If not, why not? 
  • Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator? 
  • Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients? 
  • Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction. 
  • Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. 
  • Electrocardiographic left ventricular hypertrophy predicts arrhythmia and mortality in patients with ischemic cardiomyopathy. 
  • Epidemiologic studies targeting primary cardiovascular disease prevention in South Asia. 
  • Epidemiological, demographic, and social correlates of disability among the elderly. 
  • Epidemiology and risk factors for heart failure in the elderly. 
  • Etiology of Sudden Cardiac Arrest and Death in US Competitive Athletes: A 2-Year Prospective Surveillance Study. 
  • Evaluating the impact of interventions in the Multisite Violence Prevention Study: Samples, procedures, and measures 
  • Evaluation of public health demonstration programs: the effectiveness and cost-effectiveness of WISEWOMAN. 
  • Evaluation of the All Stars character education and problem behavior prevention program: effects on mediator and outcome variables for middle school students. 
  • Evidence-based value of subcutaneous surgical wound drainage: the largest systematic review and meta-analysis. 
  • Feedback to providers improves evidence-based implantable cardioverter-defibrillator programming and reduces shocks. 
  • Focusing HIV prevention on those most likely to transmit the virus. 
  • Frontiers of Upstream Stroke Prevention and Reduced Stroke Inequity Through Predicting, Preventing, and Managing Hypertension and Atrial Fibrillation: A Call to Action From the Value in Healthcare Initiative's Predict & Prevent Learning Collaborative. 
  • Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. 
  • Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. 
  • Health care access dimensions and cervical cancer screening in South Africa: analysis of the world health survey. 
  • Health promotion interventions for disadvantaged women: overview of the WISEWOMAN projects. 
  • Helping battered women take care of their children. 
  • Hepatic complications of obesity. 
  • Heterogeneity of hemoglobin H disease in childhood. 
  • Highlights in ASCVD Primary Prevention for 2021. 
  • How bone density testing influenced osteoporosis treatment in a community hospital. 
  • How much can be gained by more systematic prevention of stroke? 
  • Impact of Genetic Testing and Family Health History Based Risk Counseling on Behavior Change and Cognitive Precursors for Type 2 Diabetes. 
  • Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey. 
  • Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. 
  • Impact of the fast track prevention program on health services use by conduct-problem youth. 
  • Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. 
  • Implantable Cardioverter Defibrillators for Nonischemic Cardiomyopathy-Reply. 
  • Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis. 
  • Implantable Defibrillators for Primary Prevention of Sudden Death in Patients on Dialysis. 
  • Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. 
  • Implantable cardioverter-defibrillators for primary prevention: how do the data pertain to the aged? 
  • Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes. 
  • Improving Hepatitis C Identification: Technology Alone Is Not the Answer. 
  • In reply. 
  • Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. 
  • Incorporating primary and secondary prevention approaches to address childhood obesity prevention and treatment in a low-income, ethnically diverse population: study design and demographic data from the Texas Childhood Obesity Research Demonstration (TX CORD) study. 
  • Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease. 
  • Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes? 
  • Is it reasonable to administer pegfilgrastim on day 1 of a myelosuppressive chemotherapy regimen? A cost-utility analysis. 
  • JACC: Heart Failure Series: FDA in the 21st Century: Focus on Nutrition and Heart Failure Prevention. 
  • JCL Roundtable. Making prevention a priority. 
  • Laparoscopic removal of gonads containing on occult seminoma in a woman with complete androgen resistance. 
  • Lessons learned in the Multisite Violence Prevention Project collaboration: Big questions require large efforts 
  • Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators. 
  • Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage. 
  • Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations. 
  • Low-Hanging Fruit for a Healthy Old Age. 
  • Management of hyperlipidemia in older adults. 
  • Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. 
  • Mediators of Effects of a Selective Family-Focused Violence Prevention Approach for Middle School Students 
  • Meta-analysis of Placebo-Controlled Randomized Controlled Trials on the Prevalence of Statin Intolerance. 
  • Minimal trauma fractures: lifting the specter of misconduct by identifying risk factors and planning for prevention. 
  • Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipients. 
  • Moderate-to-Severe Traumatic Brain Injury in Children: Complications and Rehabilitation Strategies. 
  • More about prospective health care. 
  • Mycobacteria: treatment approaches and mechanisms of resistance. 
  • New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials. 
  • Non-evidence-based ICD implantations in the United States. 
  • Novel method versus the Friedewald method for estimating low-density lipoprotein cholesterol in determination of the eligibility for statin treatment for primary prevention in the United States. 
  • Nursing care of children of battered women. 
  • Nursing research and the prevention of infectious diseases among vulnerable populations. 
  • Nutritional concerns in American Indian and Alaska Native children: transitions and future directions. 
  • Obesity prevention in schools: current role and future practice of school nurses. 
  • Obstetric hemorrhage. 
  • One-year mortality after implantable cardioverter-defibrillator placement within the Veterans Affairs Health System. 
  • Optimal management of Riata leads with no known electrical abnormalities or externalization: a decision analysis. 
  • Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis. 
  • Oral contraceptive use for the primary prevention of ovarian cancer. 
  • Ounces of prevention--the public policy case for taxes on sugared beverages. 
  • Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials. 
  • Overcoming biological, behavioral, and structural vulnerabilities: new directions in research to decrease HIV transmission in men who have sex with men. 
  • Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure. 
  • Personal Omics for Precision Health 
  • Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy. 
  • Physical Activity and Incident Heart Failure in High-Risk Subgroups: The ARIC Study. 
  • Platelet inhibitors: what are the data in women? 
  • Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. 
  • Preventability of pregnancy-related deaths: results of a state-wide review. 
  • Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. 
  • Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. 
  • Prevention and health services delivery. 
  • Prevention of cardiovascular disease: time for a course correction. 
  • Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis. 
  • Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: Diminishing Returns With Advancing Age? 
  • Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy. 
  • Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop. 
  • Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus. 
  • Primary Prevention of Heart Failure in Women. 
  • Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial. 
  • Primary care: is there enough time for prevention? 
  • Primary prevention and health services delivery. 
  • Primary prevention and statins: is it just about going to class? 
  • Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study. 
  • Primary prevention implantable cardioverter defibrillators in women: More questions than answers. 
  • Primary prevention implantable cardioverter-defibrillators and survival in older women. 
  • Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients. 
  • Primary prevention of chronic kidney disease through population-based strategies for blood pressure control: The ARIC study. 
  • Primary vs secondary prophylaxis with pegfilgrastim for the reduction of febrile neutropenia risk in patients receiving chemotherapy for non-Hodgkin's lymphoma: cost-effectiveness analyses. 
  • Primordial prevention of cardiovascular disease among African-Americans: a social epidemiological perspective. 
  • Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria. 
  • Public education and cancer control. 
  • Public preferences for prevention versus cure: what if an ounce of prevention is worth only an ounce of cure? 
  • Putting prevention in their pockets: developing mobile phone-based HIV interventions for black men who have sex with men. 
  • Quality improvement in heart rhythm care: the path forward. 
  • Quantifying cardiometabolic risk using modifiable non-self-reported risk factors. 
  • Racial differences in influenza vaccination among older Americans 1996-2000: longitudinal analysis of the Health and Retirement Study (HRS) and the Asset and Health Dynamics Among the Oldest Old (AHEAD) survey. 
  • Racial/ethnic disparities in coronary heart disease risk factors among WISEWOMAN enrollees. 
  • Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers. 
  • Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). 
  • Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT. 
  • Reduction in Inappropriate ICD Therapy in MADIT-RIT Patients Without History of Atrial Tachyarrhythmia. 
  • Regularity of preventive foot care in persons with diabetes: results from the Nord-Trøndelag Health Study. 
  • Reply: carbon monoxide treatment guidelines must acknowledge the limitations of the existing evidence. 
  • Representation of women in randomized clinical trials of cardiovascular disease prevention. 
  • Response to Letter Regarding Article, "Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women". 
  • Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease. 
  • Rheumatic Heart Disease in the Twenty-First Century. 
  • Risk factors for first time incidence sciatica: a systematic review. 
  • Same-day discharge and risks of mortality and readmission after elective ICD placement for primary prevention. 
  • School climate and implementation of the Pathways study. 
  • School-based approaches for preventing and treating obesity. 
  • Setting the stage: Research to inform interventions, practice and policy to improve women veterans' health and health care. 
  • Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated. 
  • Spatial analysis of body mass index and smoking behavior among WISEWOMAN participants. 
  • Statins for Primary Prevention in Older Adults: An Unresolved Conundrum. 
  • Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence. 
  • Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease. 
  • Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. 
  • Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. 
  • Survival is not the only valuable end point in melanoma screening. 
  • Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. 
  • Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients. 
  • Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • T wave alternans: a marker of myocardial instability. 
  • Technologies for global health. 
  • Temporal trends in clinical characteristics of patients without known cardiovascular disease with a first episode of myocardial infarction. 
  • The 1984 Hunter Oration. 
  • The Expected 30-Year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering. 
  • The Multisite Violence Prevention Project: Background and overview 
  • The Role of Prevention in Healthy Aging. 
  • The girth of a nation--a call to arms...and legs. 
  • The global need for education on cancer health. 
  • The impact of the Pathways intervention on psychosocial variables related to diet and physical activity in American Indian schoolchildren. 
  • The linkage of health status changes and disability. 
  • The new prevention. Research on causes of disease must be applied to remaking our care system. 
  • The older pedestrian. 
  • The past as prologue. 
  • The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). 
  • The proactive sexual health history. 
  • The relationship between baseline and follow-up left ventricular ejection fraction with adverse events among primary prevention ICD patients. 
  • The use of implantable cardioverter defibrillators for the prevention of sudden cardiac death: a review of the evidence and implications. 
  • Time to Revisit Using 10-Year Risk to Guide Statin Therapy. 
  • Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. 
  • Toward more optimal use of primary prevention implantable cardioverter-defibrillators: how do we get there? 
  • Toward optimal health: William P. Docken, M.D. and David S. Pisetsky, M.D., Ph.D. discuss arthritis in women. Interview by Jody R. Godfrey. 
  • Tracking radiation exposure of patients. 
  • Traumatic Brain Injury in the Elderly: Burden, Risk Factors, and Prevention. 
  • Treatment Gap in Primary Prevention Patients Presenting With Acute Coronary Syndrome. 
  • Treatments-Preventive. 
  • Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health. 
  • Use of beta-blockers in patients with an implantable cardioverter defibrillator. 
  • Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians. 
  • Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systematic literature review and meta-analysis. 
  • Using Telehealth to Disseminate Primary, Secondary, and Tertiary CVD Interventions to Rural Populations. 
  • Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action. 
  • Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. 
  • What is the future of stroke prevention?: debate: polypill versus personalized risk factor modification. 
  • When Is It Safe Not to Reimplant an Implantable Cardioverter Defibrillator at the Time of Battery Depletion? 
  • When to implant an ICD following a myocardial infarction? 
  • Women and the invention of well child care. 
  • Women's resources and use of strategies as risk and protective factors for reabuse over time. 
  • Women's willingness to accept perceived risks for vasomotor symptom relief. 
• 

  Keywords of People

  • Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
  • Dodge, Kenneth A., William McDougall Distinguished Professor of Public Policy Studies, Duke Science & Society
  • Gonzalez-Guarda, Rosa, Associate Professor in the School of Nursing, School of Nursing
  • Lusk, Jay, Affiliate, Medical Education
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Preminger, Glenn Michael, James F. Glenn, M.D. Distinguished Professor of Urology, Surgery, Urology